Literature DB >> 3302079

EORTC trials in large bowel cancer.

A Gerard, J L Berrod, J Loygue.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3302079     DOI: 10.1007/BF01648419

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  6 in total

1.  Preoperative radiation theration therapy in rectal cancer.

Authors:  M M Kligerman
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  Preoperative radiotherapy for colorectal cancer.

Authors:  G A Higgins; J H Conn; P H Jordan; E W Humphrey; B Roswit; R J Keehn
Journal:  Ann Surg       Date:  1975-05       Impact factor: 12.969

3.  Concentration of biologically active 5-fluorouracil in general circulation during continuous portal infusion in man: a preliminary report.

Authors:  O Almersjö; A Brandberg; B Gustavsson
Journal:  Cancer Lett       Date:  1975-11       Impact factor: 8.679

4.  Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.

Authors:  S Boulis-Wassif; A Gerard; J Loygue; D Camelot; M Buyse; N Duez
Journal:  Cancer       Date:  1984-05-01       Impact factor: 6.860

5.  Adjuvant liver perfusion in colorectal cancer: initial results of a clinical trial.

Authors:  I Taylor; P Brooman; J T Rowling
Journal:  Br Med J       Date:  1977-11-19

6.  Adjuvant cytotoxic liver perfusion for colorectal cancer.

Authors:  I Taylor; J Rowling; C West
Journal:  Br J Surg       Date:  1979-12       Impact factor: 6.939

  6 in total
  1 in total

1.  Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens.

Authors:  N A Shepherd; J R Jass; I Duval; R L Moskowitz; R J Nicholls; B C Morson
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.